Honz Pharmaceutical Co., Ltd. (300086.SZ)
CNY 4.36
(3.32%)
CNY 4.36
(3.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.16 Billion CNY | -5.37% |
| 2022 | 2.28 Billion CNY | -6.93% |
| 2021 | 2.45 Billion CNY | -5.93% |
| 2020 | 2.61 Billion CNY | 19.11% |
| 2019 | 2.19 Billion CNY | 0.64% |
| 2018 | 2.18 Billion CNY | -2.48% |
| 2017 | 2.23 Billion CNY | 2.12% |
| 2016 | 2.18 Billion CNY | 4.77% |
| 2015 | 2.08 Billion CNY | 8.45% |
| 2014 | 1.92 Billion CNY | 1.19% |
| 2013 | 1.9 Billion CNY | -3.26% |
| 2012 | 1.96 Billion CNY | 0.2% |
| 2011 | 1.96 Billion CNY | 3.16% |
| 2010 | 1.9 Billion CNY | 547.64% |
| 2009 | 294.08 Million CNY | 42.53% |
| 2008 | 206.33 Million CNY | 45.75% |
| 2007 | 141.57 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.08 Billion CNY | -2.12% |
| 2024 Q1 | 2.13 Billion CNY | -1.59% |
| 2024 Q3 | 2.08 Billion CNY | 0.08% |
| 2023 Q2 | 2.14 Billion CNY | -0.18% |
| 2023 FY | 2.16 Billion CNY | -5.37% |
| 2023 Q4 | 2.16 Billion CNY | 3.73% |
| 2023 Q3 | 2.08 Billion CNY | -2.68% |
| 2023 Q1 | 2.14 Billion CNY | -6.09% |
| 2022 Q3 | 2.22 Billion CNY | -1.48% |
| 2022 Q4 | 2.28 Billion CNY | 2.93% |
| 2022 FY | 2.28 Billion CNY | -6.93% |
| 2022 Q1 | 2.35 Billion CNY | -4.05% |
| 2022 Q2 | 2.25 Billion CNY | -4.35% |
| 2021 Q2 | 2.58 Billion CNY | 0.93% |
| 2021 Q4 | 2.45 Billion CNY | 2.58% |
| 2021 FY | 2.45 Billion CNY | -5.93% |
| 2021 Q1 | 2.55 Billion CNY | -2.19% |
| 2021 Q3 | 2.39 Billion CNY | -7.11% |
| 2020 Q2 | 2.4 Billion CNY | 0.57% |
| 2020 Q3 | 2.52 Billion CNY | 4.85% |
| 2020 Q4 | 2.61 Billion CNY | 3.69% |
| 2020 FY | 2.61 Billion CNY | 19.11% |
| 2020 Q1 | 2.39 Billion CNY | 8.93% |
| 2019 Q3 | 2.19 Billion CNY | 2.1% |
| 2019 Q2 | 2.14 Billion CNY | -2.45% |
| 2019 FY | 2.19 Billion CNY | 0.64% |
| 2019 Q1 | 2.2 Billion CNY | 0.99% |
| 2019 Q4 | 2.19 Billion CNY | 0.06% |
| 2018 Q3 | 2.24 Billion CNY | -3.52% |
| 2018 Q1 | 2.23 Billion CNY | 0.17% |
| 2018 Q2 | 2.33 Billion CNY | 4.1% |
| 2018 Q4 | 2.18 Billion CNY | -3.07% |
| 2018 FY | 2.18 Billion CNY | -2.48% |
| 2017 Q3 | 2.15 Billion CNY | 0.19% |
| 2017 FY | 2.23 Billion CNY | 2.12% |
| 2017 Q4 | 2.23 Billion CNY | 3.79% |
| 2017 Q2 | 2.15 Billion CNY | 0.87% |
| 2017 Q1 | 2.13 Billion CNY | -2.64% |
| 2016 Q2 | 2.14 Billion CNY | -0.73% |
| 2016 Q1 | 2.16 Billion CNY | 3.46% |
| 2016 FY | 2.18 Billion CNY | 4.77% |
| 2016 Q4 | 2.18 Billion CNY | 1.57% |
| 2016 Q3 | 2.15 Billion CNY | 0.43% |
| 2015 Q3 | 1.96 Billion CNY | 0.93% |
| 2015 Q4 | 2.08 Billion CNY | 6.48% |
| 2015 Q1 | 1.9 Billion CNY | -0.9% |
| 2015 FY | 2.08 Billion CNY | 8.45% |
| 2015 Q2 | 1.94 Billion CNY | 1.82% |
| 2014 FY | 1.92 Billion CNY | 1.19% |
| 2014 Q4 | 1.92 Billion CNY | -0.66% |
| 2014 Q3 | 1.93 Billion CNY | 0.99% |
| 2014 Q2 | 1.92 Billion CNY | 0.14% |
| 2014 Q1 | 1.91 Billion CNY | 0.72% |
| 2013 Q3 | 1.93 Billion CNY | -0.19% |
| 2013 Q4 | 1.9 Billion CNY | -1.47% |
| 2013 FY | 1.9 Billion CNY | -3.26% |
| 2013 Q1 | 1.96 Billion CNY | -0.27% |
| 2013 Q2 | 1.93 Billion CNY | -1.35% |
| 2012 Q3 | 1.95 Billion CNY | -0.45% |
| 2012 Q4 | 1.96 Billion CNY | 0.65% |
| 2012 Q2 | 1.96 Billion CNY | -0.86% |
| 2012 FY | 1.96 Billion CNY | 0.2% |
| 2012 Q1 | 1.98 Billion CNY | 0.86% |
| 2011 FY | 1.96 Billion CNY | 3.16% |
| 2011 Q2 | 1.95 Billion CNY | -4.06% |
| 2011 Q3 | 1.95 Billion CNY | -0.11% |
| 2011 Q4 | 1.96 Billion CNY | 0.49% |
| 2011 Q1 | 2.04 Billion CNY | 7.12% |
| 2010 Q4 | 1.9 Billion CNY | 4.23% |
| 2010 Q3 | 1.82 Billion CNY | 2.84% |
| 2010 Q1 | 338.85 Million CNY | 15.22% |
| 2010 Q2 | 1.77 Billion CNY | 424.41% |
| 2010 FY | 1.9 Billion CNY | 547.64% |
| 2009 FY | 294.08 Million CNY | 42.53% |
| 2009 Q4 | 294.08 Million CNY | 0.0% |
| 2008 FY | 206.33 Million CNY | 45.75% |
| 2007 FY | 141.57 Million CNY | 0.0% |